PQQ
Best-in-class: PQQ
A compound that stimulates the growth of NEW mitochondria (mitochondrial biogenesis) — a rare property — plus antioxidant and nerve-growth-factor support.
PQQ quick facts
| Suggested dose | 10–20 mg daily; often paired with CoQ10. |
| How often | Daily |
| Who it's for | Mitochondrial energy, cognitive and longevity support. |
The biogenesis mechanism is well demonstrated in cell and animal work; the human outcome data is thin and mostly small Japanese trials on fatigue and cognition. Frequently paired with CoQ10 on the logic that new mitochondria need the electron carrier to function — coherent reasoning, unproven as a combination. Genuinely promising and genuinely under-evidenced.
How PQQ actually works
Pyrroloquinoline quinone activates PGC-1alpha, the master transcriptional regulator of mitochondrial biogenesis — so the claim is more mitochondria rather than better-functioning existing ones, which is a genuinely different mechanism from CoQ10 or Urolithin A. It is also a redox cofactor capable of many thousands of catalytic cycles without degrading, unlike most antioxidants.
Where to get PQQ
Find PQQ on iHerb →The evidence for PQQ
Graded by what exists behind each claim.
✅ Clinically validated
- Small human studies show improved markers of mitochondrial function, reduced fatigue, and better sleep/mood.
- Stimulates mitochondrial biogenesis and protects against oxidative stress in research.
📊 Correlative data
- Mitochondrial density declines with age, tracking with fatigue and metabolic slowdown.
🧪 Theoretical / extrapolated benefits
- Cognitive and longevity claims follow from the mitochondrial mechanism; human data is still limited.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What PQQ actually does
Pyrroloquinoline quinone is a redox cofactor for bacterial enzymes, and whether it is a cofactor for any human enzyme is unsettled. In methylotrophic bacteria it is the prosthetic group of methanol and glucose dehydrogenases. In mammals no PQQ-dependent enzyme has been definitively identified, which is why the careful reviews describe it as a vitamin-like accessory factor rather than as a vitamin Jonscher 2021.
What it demonstrably is, is an unusually durable redox cycler. The ortho-quinone can accept and donate electrons repeatedly — thousands of catalytic cycles before degradation, against a handful for ascorbate — which is the basis for the antioxidant framing. That is a chemical property measured in a cuvette rather than a demonstrated action in a person.
The mechanism the products are actually sold on is mitochondrial biogenesis. PQQ has been reported to activate the PGC-1alpha pathway, through CREB phosphorylation and through downstream nuclear respiratory factor and mitochondrial transcription factor A signaling, increasing mitochondrial number in cell and rodent systems Jonscher 2021. Biogenesis is the opposite half of the cycle from the mitophagy story on the urolithin page, and the two are frequently sold together without that being noted.
There is a second proposed mechanism that is more specific and less advertised. PQQ reacts with amino groups to form imidazolopyrroloquinoline adducts, and it interacts with the NMDA receptor redox modulatory site, which is the basis for the neuroprotection claims and the reason the neurodegeneration literature treats it as a metabolic rather than an antioxidant intervention Canovai 2025.
And the dietary case rests on a deprivation experiment in animals. PQQ-deprived rodents show impaired growth, reduced reproductive performance and altered mitochondrial content, which reverses on repletion. That is the strongest argument that it does something in a mammal, and it has never been reproduced in a human because nobody can construct a PQQ-free human diet Jonscher 2021.
Cell, rodent, human — and where it stops
This is the thinnest human evidence base in the cohort, and the honest description of it is that the surrogate has not been measured properly either.
In cells and rodents the biogenesis signal is reproducible. PGC-1alpha activation, increased mitochondrial DNA copy number and improved metabolic parameters appear across independent rodent studies, and the reviews summarize a consistent preclinical picture Jonscher 2021 Canovai 2025.
The reproductive and metabolic work is also animal work. A role for coenzyme Q10 and PQQ in mitigating obesity-associated reproductive dysfunction has been described in that literature Castillo-Castrejon 2025, which is a mechanistically coherent extension and not a human result.
The human trials that exist are small and recent. A randomized controlled trial of six weeks of a dihydrogen-PQQ preparation in elderly individuals with mild cognitive impairment measured mitochondrial biomarkers, brain metabolism and cognition together Baltic 2024, and a randomized, double-blind, placebo-controlled study examined PQQ with nicotinamide mononucleotide on interoception after exhaustive exercise Zhao 2026.
The obstacle to transfer is that neither of those tested PQQ alone at a consumer dose against a clinical endpoint. One used a modified preparation in a clinical population; the other used a combination product and an unusual outcome measure. Neither answers what a 20 mg capsule does for a healthy adult.
And the marker this product should own has never been measured in people. If PQQ works by mitochondrial biogenesis, the read-out is mitochondrial DNA copy number or citrate synthase activity in muscle. No human trial has reported either after PQQ supplementation, which means the central mechanistic claim has no human surrogate at all Jonscher 2021.
PQQ — which form, and does it matter
The disodium salt is what almost every product contains, and it is a manufacturing choice. Free PQQ is poorly soluble and unstable; the disodium salt is the stabilized crystalline form used in the safety notifications and in the trials. It is roughly 90 percent PQQ by weight, so a 20 mg disodium dose is about 18 mg of PQQ.
The reduced forms are the newer claim and one has been tested in a trial. Dihydrogen-PQQ, the reduced quinol, is proposed to be more stable and more readily absorbed, and it is the material used in the mild cognitive impairment trial Baltic 2024. A reader comparing products should note that the oxidized disodium salt and the reduced form are not the same molecule and do not share the same evidence.
The exposure numbers are known in outline and thin in detail. Oral PQQ disodium is absorbed with an oral bioavailability of roughly 60 to 80 percent in animal work, peaks in plasma at about 1 to 2 hours, and is largely excreted unchanged by renal clearance within 24 hours, with a plasma half-life on the order of 2 to 5 hours. There is no cytochrome oxidation step and no substantial first-pass metabolism — the molecule is a redox catalyst that is not consumed, which is why it is cleared rather than degraded Jonscher 2021.
That fast clearance sits awkwardly with the mechanism. Mitochondrial biogenesis is a process of days to weeks; the compound is gone in a day. Either the effect is transcriptional and persists, as with sulforaphane, or the daily dose is doing something acute. Nobody has established which, and no trial has tested twice-daily against once-daily dosing.
The dose gap between the shelf and the diet is the largest in this catalog. Estimated dietary intake from food — natto, parsley, green tea, kiwi — is on the order of tens of MICROgrams a day. Supplements supply 10 to 20 MILLIgrams. That is roughly a thousandfold, and no dose-ranging study in humans supports the number chosen Jonscher 2021.
What would have to be true, and how you would know it was not
1. Predict that no accessible marker moves, and treat that as the finding. Predict no change in any standard panel on 20 mg a day. There is no clinically available PQQ status test and no validated surrogate, which is worth knowing before spending money on a mechanism that cannot be checked Jonscher 2021.
2. Predict the mechanism marker would be a muscle measurement. Predict that mitochondrial DNA copy number or citrate synthase activity in a muscle biopsy is where a biogenesis effect would appear, and predict that no published human study has reported it after PQQ. A trial that did would be the first real evidence for the category.
3. The prediction that cuts against the product. Predict that a randomized trial of PQQ alone at 20 mg a day in healthy adults, with objective cognitive or exercise endpoints over 12 weeks, returns a null result, because the existing human trials used a different preparation in a clinical population Baltic 2024 or a combination product Zhao 2026. A clean positive trial would falsify this page.
4. Predict the combination trials cannot be attributed. Predict that a study of PQQ with nicotinamide mononucleotide, or with coenzyme Q10, cannot tell you what PQQ contributed Zhao 2026 Castillo-Castrejon 2025. A factorial design is the only way to find out and none has been run.
5. Predict sleep and fatigue reports are where any subjective effect will show, and predict they will not survive blinding. Predict improvements on self-rated sleep and fatigue questionnaires in an open-label setting, and predict the difference against placebo in a blinded trial is much smaller. That is the pattern for every supplement whose endpoint is a questionnaire.
What nobody has tested yet
Whether humans have a PQQ-dependent enzyme is genuinely unknown. Candidate assignments have been proposed and withdrawn, and the current position in the careful literature is that PQQ is vitamin-like rather than a vitamin Jonscher 2021. If no human enzyme requires it, the deficiency framing on which the category rests is wrong.
Nobody has measured mitochondrial biogenesis in a supplemented human. That measurement is available, it is the central claim, and it has not been made. Its absence after two decades of commercial sale is the most striking fact on this page.
The dose has no rational basis. The jump from microgram dietary intakes to 20 mg capsules was not derived from a dose-ranging study Jonscher 2021. Whether 5 mg does the same thing, or 100 mg does more, is unexamined in people.
And the neurodegeneration hypothesis is preclinical. The metabolic and neuroprotective case has been argued in detail from animal and cell data Canovai 2025, and the single relevant human trial used a different preparation in mild cognitive impairment Baltic 2024. Replication with the marketed material is the next step and has not happened.
PQQ — its own safety story, not its category's
Short-term human safety data exist and they are limited to small trials. The randomized studies in mild cognitive impairment and in exercise reported acceptable tolerability at the doses used Baltic 2024 Zhao 2026. There is no established tolerable upper intake level and no long-term data.
The specific signal from animal toxicology is renal. High-dose PQQ has produced kidney injury in rodents at doses well above human supplemental intake, and because the compound is cleared essentially unchanged by the kidney, that is the organ that sees the highest concentration. Anyone with reduced kidney function has a mechanistic reason for caution that most supplements do not carry.
Common reported effects are mild. Headache, drowsiness or sleep disturbance, and gastrointestinal upset, none of them characterized in a controlled way at the doses on sale.
The interaction profile is unexamined rather than clean. No cytochrome-mediated interactions are expected from a compound that is not metabolized by them, and a redox-cycling quinone taken alongside chemotherapy or radiotherapy is an antioxidant question that belongs to an oncology team. No clinical interaction study has been published.
Who this is not established for, which is most people. Pregnancy, lactation and children have no data. Anyone with kidney disease has a reason to avoid it. And anyone buying it for mitochondrial biogenesis should know that the claim has never been measured in a person Jonscher 2021. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.
Sources read for this page
- Jonscher KR. Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention. Biomolecules 2021 · PMID 34680074
- Baltic S. The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial. J Nutr Health Aging 2024 · PMID 38908296
- Canovai A. Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism. Neural Regen Res 2025 · PMID 38767475
- Zhao C. The effects of pyrroloquinoline quinone and nicotinamide mononucleotide supplementation on interoception following acute exhaustive exercise: a randomized, double-blind, placebo-controlled study. Sci Rep 2026 · PMID 41651893
- Castillo-Castrejon M. A role for the antioxidants coenzyme Q10 and pyrroloquinoline quinone in mitigating obesity-associated reproductive dysfunction. Biol Reprod 2025 · PMID 40810470
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Fatigue at a fixed point in the day, scored the same way each time — the three o'clock hour rather than energy in the abstract — plus hours slept and how you rate the first hour after waking. The small human studies here reported fatigue, sleep and mood, so those are the endpoints to copy, and they are also the ones most likely to be moving for other reasons.
- How long before it means anything: Six to eight weeks. Mitochondrial biogenesis, if it is happening, is a structural change on the scale of weeks — and there is no test on any menu that shows whether new mitochondria appeared.
- What will fool you: Everything else that moves fatigue, which is nearly everything: sleep, caffeine, training load, iron, thyroid, mood, daylight. Fatigue is the least specific complaint in medicine and the easiest to shift with expectation. If the tiredness is new, persistent or worsening, it deserves a work-up rather than a capsule — the common causes are all things a blood test finds.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
PQQ — safety & side effects
- Well tolerated at typical doses (10–20 mg). Headache and drowsiness at higher doses.
- Kidney injury has been reported at very high doses in animal studies — there is no reason to exceed 20 mg/day and no evidence of benefit from doing so.
- Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade. No established drug interactions.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — PQQ in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside PQQ
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
PQQ — frequently asked questions
What is PQQ?
A compound that stimulates the growth of NEW mitochondria (mitochondrial biogenesis) — a rare property — plus antioxidant and nerve-growth-factor support.
What is the suggested dose of PQQ?
10–20 mg daily; often paired with CoQ10. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find PQQ dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy PQQ?
Coach Cam sources PQQ from vetted, top-rated brands on iHerb — use the buy link on this page.
PQQ inside a finished plan
One arm of 3 Protocol Blueprints, free to read in full.
What PQQ is used for
PQQ appears under 5 goals in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
PQQ is the autophagy arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.